Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

TDAC·NASDAQ

$10.75

-0.19%
Financial ServicesShell Companies

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

At a Glance

Live Snapshot
Market Cap$235.51M
EPS0.3700
P/E Ratio28.44
Earnings Date05/15/2026

tdac

Operating Expenses

Last Annual Value

944.54K

3-Year CAGR

137%

5-Year CAGR

68%

10-Year CAGR

30%

Translational Development Acquisition Corp.

Translational Development Acquisition Corp. Competitors Analysis of Operating Expenses

TDAC · NASDAQ
CompanyOperating Expenses
CAGR 3Y
CAGR 5Y
CAGR 10Y
944.54K
24.8%N/AN/A 
973.56K
6772.0%N/AN/A
537.45K
N/A-9.7%N/A
2.23M
-61.5%-10.1%N/A
1.92M
N/A161.1%N/A
688.45K
N/AN/AN/A
Translational Development Acquisition Corp.

Translational Development Acquisition Corp. Fair Value Envelope

TDAC · NASDAQ

Our analysis suggests that TDAC has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $10.75, this represents a potential HIDDEN relative to our calculated worth for Translational Development Acquisition Corp..

Intrinsic Value
Current Price: $10.75